Piper Sandler analyst Yasmeen Rahimi raised the firm’s price target on Prothena (PRTA) to $110 from $94 and keeps an Overweight rating on the shares. The firm notes Prothena has multiple key ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback